The Medical journal of Australia
-
Randomized Controlled Trial Multicenter Study Comparative Study Clinical Trial
Nebuhaler versus wet aerosol for domiciliary bronchodilator therapy. A multi-centre clinical comparison.
To compare the clinical effectiveness and patient acceptance of a large spacer device (Nebuhaler) for delivery of metered dose aerosol (MDI) terbutaline with nebulised wet aerosol terbutaline. ⋯ MDI terbutaline delivered via Nebuhaler provides clinical benefit similar to that of wet aerosol terbutaline in the long-term domiciliary management of patients with stable airflow obstruction.